Utah Medical Products, Inc. (NASDAQ:UTMD) Declares Quarterly Dividend of $0.31

Key Points

• Utah Medical Products, Inc. has declared a quarterly dividend of $0.31 per share, which is set to be paid on October 2nd, representing an annualized dividend of $1.22 and a yield of 2.16%.
• The company's stock is currently down 0.1%, trading at $56.38, with a market capitalization of $183.24 million and a P/E ratio of 15.07.
• Institutional investors own 69.60% of Utah Medical Products, with Jane Street Group recently acquiring a new stake valued at approximately $317,000.

Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) announced a quarterly dividend on Wednesday, July 30th, Wall Street Journal reports. Investors of record on Wednesday, September 17th will be given a dividend of 0.305 per share by the medical instruments supplier on Thursday, October 2nd. This represents a c) annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Wednesday, September 17th.

Utah Medical Products Price Performance

Shares of UTMD stock traded down $0.04 on Friday, hitting $55.57. The stock had a trading volume of 4,314 shares, compared to its average volume of 18,436. The company's 50 day moving average price is $56.13 and its 200-day moving average price is $56.83. Utah Medical Products has a 1 year low of $51.26 and a 1 year high of $69.30. The firm has a market capitalization of $180.48 million, a P/E ratio of 14.86 and a beta of 0.28.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $0.94 EPS for the quarter. Utah Medical Products had a return on equity of 10.50% and a net margin of 32.34%. The business had revenue of $9.95 million for the quarter.

Institutional Trading of Utah Medical Products

Hedge funds have recently added to or reduced their stakes in the stock. American Century Companies Inc. lifted its holdings in shares of Utah Medical Products by 8.6% in the 4th quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier's stock valued at $500,000 after buying an additional 643 shares during the period. LPL Financial LLC acquired a new stake in shares of Utah Medical Products in the 4th quarter valued at approximately $208,000. JPMorgan Chase & Co. lifted its holdings in shares of Utah Medical Products by 14.8% in the 4th quarter. JPMorgan Chase & Co. now owns 79,703 shares of the medical instruments supplier's stock valued at $4,899,000 after buying an additional 10,292 shares during the period. New Age Alpha Advisors LLC acquired a new stake in shares of Utah Medical Products in the 4th quarter valued at approximately $101,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Utah Medical Products by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 97,937 shares of the medical instruments supplier's stock valued at $6,022,000 after buying an additional 857 shares during the period. 69.60% of the stock is owned by institutional investors and hedge funds.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.